Insulet Takes Another Step Closer To Introduce Artificial Pancreas
Another established device maker is throwing its hat in the ring of artificial pancreas development.
Insulet, the maker of the tubeless insulin pump, announced Tuesday that the first patient has completed the feasibility study to test its OmniPod Horizon Automated Glucose Control System, a hybrid closed loop system intended for patients that depend on insulin or type 1 diabetes patients.
Insulet, the maker of the tubeless insulin pump, announced Tuesday that the first patient has completed the feasibility study to test its OmniPod Horizon Automated Glucose Control System, a hybrid closed loop system intended for patients that depend on insulin or type 1 diabetes patients.